Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2020
DOI: 10.17925/ee.2020.16.2.97
|View full text |Cite
|
Sign up to set email alerts
|

Takotsubo Endocrinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“… 6 Furthermore, recent studies have shown that endocrine disorders, such as hyperthyroidism, pheochromocytoma, and primary aldosteronism, are associated with TCM onset. 7 The patient had been taking yokukansan, a licorice‐containing (1.5 g/day) Kampo drug, for over 10 years. According to the Japanese Adverse Drug Reports Database, yokukansan is associated with a low incidence of side effects.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 6 Furthermore, recent studies have shown that endocrine disorders, such as hyperthyroidism, pheochromocytoma, and primary aldosteronism, are associated with TCM onset. 7 The patient had been taking yokukansan, a licorice‐containing (1.5 g/day) Kampo drug, for over 10 years. According to the Japanese Adverse Drug Reports Database, yokukansan is associated with a low incidence of side effects.…”
Section: Discussionmentioning
confidence: 99%
“…Many studies have shown that TCM precipitated by either physical or unidentified triggers has poorer short‐ and long‐term cardiovascular outcomes than TCM precipitated by emotional triggers 6 . Furthermore, recent studies have shown that endocrine disorders, such as hyperthyroidism, pheochromocytoma, and primary aldosteronism, are associated with TCM onset 7 . The patient had been taking yokukansan, a licorice‐containing (1.5 g/day) Kampo drug, for over 10 years.…”
Section: Discussionmentioning
confidence: 99%
“…Catecholamine-driven cardiac impairment may arise from direct cardiotoxicity via myocardial catecholamine-receptor signalling, microvascular ischemia, and transient coronary artery vasospasm [ 5 ]. It has been suggested that all patients with suspected Takotsubo cardiomyopathy should be evaluated for underlying endocrine drivers, such as pheochromocytoma and thyrotoxicosis [ 6 ]. Our patient in the second case likely developed acute Takotsubo cardiomyopathy related to pheochromocytoma, with the inflammatory change around the upper pole of the right kidney more likely to represent non-specific changes related to her acute crisis.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the predominance of postmenopausal women, no study has provided evidence on the association between sex hormone levels and Takotsubo cardiomyopathy. 4 The pathophysiology of Takotsubo cardiomyopathy is complex, with multiple mechanisms theorised to be involved. The neuroendocrine axis is proposed to be involved, with catecholamine-mediated myocardial damage due to either direct toxicity and/or microvascular dysfunction as well as sensitisation of the myocardial tissue to sympathetic hormones by thyroid hormones exacerbating the catecholaminergic-mediated myocardial tissue damage through synergism.…”
Section: Case Reportmentioning
confidence: 99%